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mtDNA replicationprotein family, identiﬁed in Metazoa and plants, which consists of 4 subfamilies
named MTERF1–4. Proteins belonging to this family are localized in mitochondria and show a modular
architecture based on repetitions of a 30 amino acid module, the mTERF motif, containing leucine zipper-like
heptads. The MTERF family includes the characterized transcription termination factors human mTERF, sea
urchin mtDBP and Drosophila DmTTF. In vitro and in vivo studies show that these factors play different roles
which are not restricted to transcription termination, but concern also transcription initiation and the control
of mtDNA replication. The multiplicity of functions could be related to the differences in the gene
organization of the mitochondrial genomes. Studies on the function of human and Drosophila MTERF3 factor
showed that the protein acts as negative regulator of mitochondrial transcription, possibly in cooperation
with other still unknown factors. The complete elucidation of the role of the MTERF family members will
contribute to the unraveling of the molecular mechanisms of mtDNA transcription and replication.
© 2009 Elsevier B.V. All rights reserved.1. The MTERF protein family
Oxidative phosphorylation is a fundamental process for eukaryotic
cells. It takes place in mitochondria and is carried out by an enzymatic
apparatus consisting of polypeptides encoded by both nuclear and
mitochondrial genes. The production and assembling of these
subunits require the coordinated expression of the two genomes
that is based on signalling pathways between nucleus and cytoplasm
[for review see refs. 1,2]. A consistent amount of studies has been
focused on the mechanisms of transcription of mtDNA encoded genes.
Although the emerging picture is far to be exhaustive, we have now
reached a good level of knowledge that highlights some peculiar
aspects of this process [for review see refs. 3,4]. The basal transcription
apparatus consists of a phage-like mitochondrial RNA polymerase
(mtRNAP) and the activation factors TFAM and TFB1/2M. Recently,
several studies have been focused on the members of the MTERF
protein family, whose founder member is human mTERF, the ﬁrst
characterized mitochondrial transcription termination factor. MTERF
proteins have been identiﬁed in Metazoa and plants, but not in fungi.
The evolutionary relationships of MTERF proteins have been described
in Metazoa [5]; in vertebrates three mTERF paralogues have been
found which, together with mTERF, identify four sub-families, named
MTERF1 through MTERF4. Sub-families MTERF1, which includes thee Biologia Molecolare “Ernesto
, 4, 70125 Bari, Italy. Tel.: +39
tatore).
ll rights reserved.termination factor mTERF, and MTERF2 are unique to vertebrates;
sub-families MTERF3 and MTERF4 also include members from insects
and worms, thus probably representing the ancestral MTERF genes in
Metazoa. Some other MTERF proteins do not apparently belong to any
of the deﬁned sub-families (see 2.4).
The characterized proteins of this family are localized in mito-
chondria and have a modular architecture due to the repetition of a
variable number of a 30 amino acid motif namedmTERFmotif [6]. The
distinctive feature of this motif is the conservation of a proline residue
at position 8, and of a leucine or another hydrophobic amino acid at
positions 11, 18 and 25; this suggests the existence of three leucine
zipper (LZ)-like heptads X3LX3 inside the mTERF motif.
This paper focuses on the MTERF family members in animal
organisms. We will review the structure and function of the
characterized proteins of this family and will also include some
unpublished results from our laboratory. All together, the information
here reported brings new insights into the mitochondrial transcrip-
tion regulation and also show that some proteins of this family serve
multiple roles, possibly related to the peculiar organization of the
mitochondrial genomes in different organisms.
2. The mitochondrial transcription termination factors
2.1. mTERF, the human transcription termination factor
Human mTERF is a 342-amino acid protein (mature form) that was
shown to arrest in vitro mitochondrial RNA polymerase (mtRNAP)
progressionby speciﬁcally bindinga 28nt sequence located immediately
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tRNALeu(UUR) gene [7,8]. On the basis of such properties mTERF was
proposed to control mtDNA transcription. In mammals H-strand
transcription proceeds through two partially overlapping units. One of
them, the ribosomal unit, starts at the initiation site H1 and ends at the
3′ end of the 16S rRNA gene. It is responsible for the synthesis of the
two rRNAs, of tRNAPhe and tRNAVal. The second transcription unit
begins at the initiation site H2 and produces a polycistronic molecule
covering almost the entire H-strand. It was reported that H1 initiation
site is more frequently used than H2 site, resulting in a higher rate of
rRNAs transcription [9,10]. Transcription of the ribosomal unit is
linked to a termination event operated by mTERF through its binding
to the 3′ end of the 16S rRNA gene. This would account for the higher
(40–50 folds) level of rRNAs with respect to mRNAs. Asin-Cayuela
et al. [11] demonstrated that recombinant mTERF, bound to its
canonical binding site, is able to promote termination in a bidirec-
tional way, with an even higher efﬁciency when the mtRNAP
transcribes in the L-strand direction. This event is consistent with
the absence of genes downstream of the factor binding site.
Recent evidence indicates that the role of mTERF is probably more
complex than initially thought. By using an artiﬁcial rDNA template
bearing the termination and H1 initiation transcription sites, Martin et
al. [12] showed that native mTERF causes not only transcription arrest
but also transcription activation. This is due to the ability of one single
mTERF molecule to simultaneously bind the well-known termination
site and a novel site placed in the H1 region. Such double interaction
causes the looping-out of the rDNA that would promote the recycling
of the transcription machinery through the direct delivery of the
mtRNAP from the termination site to the H1 initiation site. This model
would account for the higher rate of transcription of rDNA compared
tomRNA genes, thus providing the basic molecular mechanism for the
regulation of the rRNA/mRNA ratio.
In spite of the plenty of information obtained by in vitro studies,
there are no in vivo experimental evidences supporting the termina-
tion role of mTERF. In fact, in vivo alteration of mTERF level does not
seem to affect the content of mitochondrial transcripts [13]. Informa-
tion on the in vivo role of mTERF are not even provided by the analysis
of cells harbouring the A3243G MELAS mutation. This nucleotide
substitution, which falls within the mTERF binding site, was shown in
vitro to reduce the afﬁnity of mTERF to DNA and to cause a decrease in
termination efﬁciency [14]. However, in vivo footprinting analysis of
mutant and wild type mtDNAs did not reveal any difference in the
occupancy of mTERF binding site [15]. This ﬁnding explains why in
MELAS mutation carrying cells the ratio between transcripts mapping
upstream and downstream of the termination site remains unchanged
[16]. Recent evidences indicate that mTERF, in addition to its role in
transcription, may play a role in modulating mtDNA replication. In
human cultured cells over-expressing mTERF, the protein level
modulates replication pausing at the canonical binding site as well
as at novel contacted sequences [13]. These observations represent
open questions on the role of humanmTERF, which still await deﬁnite
answers.
2.2. mtDBP, the sea urchin transcription termination factor
The different mtDNA gene organization in invertebrates compared
to vertebrates prompted interest on the basic transcription mechan-
isms and on the functioning of the transcription factors, which might
have evolved to meet structural changes occurred in the genomes
during evolution. In particular, many studies have been focused on two
experimental systems: the sea urchin and theDrosophilamelanogaster.
mtDNA from sea urchin Paracentrotus lividus contains the same
genes found in vertebrates but with a different arrangement [17]. The
ribosomal genes are separated by a region of 3.3 kbp containing a
cluster of 15 tRNA genes and the genes for ND1, ND2; the main non-
coding region, NCR, is very short (132 bp) and is located in the tRNAgene cluster downstream of the 12S rRNA gene. In this organism
mitochondrial transcription seems to occur via multiple and partially
overlapping transcription units [18], but the precise initiation sites
have not been deﬁned to date.
We characterized a 348-amino acid DNA binding protein, mtDBP,
which binds with high afﬁnity two sites of sea urchin mtDNA. The
ﬁrst is located in the NCR at the 3′ end of the short D-loop structure,
the second comprises the 3′ ends of the oppositely transcribed ND5
and ND6 genes [19]. The observation that mtDBP displays a
signiﬁcant homology with human mTERF suggested that the sea
urchin protein could possess a transcription termination activity [20].
This hypothesis was demonstrated by an in vitro transcription assay
performed in the presence of the recombinant sea urchin proteins
mtDBP and mtRNAP [21]. In this reconstituted system, termination of
transcription in the NCR occurred in an mtDBP-dependent manner
when the enzyme approached the protein binding site in the
direction of L-strand transcription (that is, the direction of synthesis
of the H-strand primer). Instead, when the polymerase encountered
the protein binding site in the opposite direction, termination
occurred independently of the presence of mtDBP, within the protein
binding site (Fig. 1A). The conclusions are that sea urchin mtDBP acts
as a polar termination factor and that mitochondrial transcription
termination may take place by two alternative modes based on
protein-dependent and sequence-dependent mechanisms.
The observation that the mtDBP target site in the NCR coincides
with the 3′ end of the small sea urchin D-loop arose the question
whether mtDBP might control the expansion of the D-loop. Loguercio
Polosa et al. [22] demonstrated that the protein has also a contraheli-
case activity, thus suggesting a role as negative regulator of
replication. Furthermore, it was observed that H-strand readthrough
transcription co-existing with the event of sequence-dependent
termination at mtDBP binding site causes dislodging of mtDBP (Fig.
1B); this event, in turn, would cause abrogation of helicase
impairment and possible resumption of mtDNA replication. Therefore,
it is likely that mtDBP is the molecular device that regulates a possible
interplay between mtDNA transcription and replication in sea urchin
mitochondria.
2.3. DmTTF, the Drosophila transcription termination factor
Drosophila melanogastermtDNA has a size of about 19.5 kDa, due to
a large non-coding region of about 4.6 kbp mainly composed by A and
T [23]. Its gene organization is markedly different from that of human
and sea urchin genomes; in fact the genes on Drosophila mtDNA are
almost equally distributed between the two strands and form four
clusters that are located alternatively on the two strands (Fig. 2).
Early mapping data of discrete and precursor mitochondrial RNAs
suggested that Drosophila mtDNA could be transcribed by multiple
transcription units starting in correspondence of the 5′ end of the
gene blocks [24]. In addition, several transcription termination sites at
the end of these blocks were hypothesized. We have identiﬁed and
characterized DmTTF, a Drosophila homologue of human mTERF and
sea urchin mtDBP [25]. The protein binds two homologous short non-
coding sequences located at the end of blocks of genes transcribed in
opposite direction. One sequence is placed between tRNAGlu and
tRNAPhe genes; the other is placed between tRNASer(UCN) and ND1
genes. Interestingly, the location of these sequences coincides with
two transcription termination sites previously predicted [24]. All these
observations suggested for DmTTF a role as transcription termination
factor. Such function was conﬁrmed by assessing the capability of the
recombinant protein to arrest in vitro mitochondrial transcription in
the presence of human mtRNAP and a chimeric DNA template
containing human HSP promoter and DmTTF binding site [26].
The role of DmTTFwas subjected to a detailed in vivo analysis byour
group. As a ﬁrst step in this investigation, we analysed a DmTTF knock-
down phenotype produced in D.Mel-2 cells by RNA interference
Fig. 1. Schematic diagram representing the role of mtDBP in transcription and replication of sea urchin mtDNA. (A) The region of P. lividus mtDNA containing the main non-coding
region (NCR) with bound mtDBP is shown. Arrowed wavy lines below the scheme represent transcripts arrested by sequence-dependent and mtDBP-dependent termination events,
with points of transcription arrest indicated by vertical dotted lines. The scheme also shows that H-DNA synthesis is arrested by the contrahelicase activity of DNA-boundmtDBP, thus
forming the triple-stranded structure of the D-loop. The nascent chain is composed of the RNA primer (70–80 nt) and a short DNA tract (about 20 nt). (B) H-strand transcription
through mtDBP–DNA complex (readthrough transcription) in the opposite direction of H-strand replication causes dislodging of mtDBP; this relieves the block to helicase, H-DNA
synthesis is restarted and the D-loop is expanded.
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depletion did not affect the 3′ end formation of the tRNASer(UCN)
molecule that maps just upstream of one of the protein binding sites.
This implies that the termination factor is not involved in the generation
of the 3′ end of transcripts.
A detailed characterization of the steady-state level of sense and
antisense transcripts by Real Time RT-PCR showed that in knock-down
cells the level of the transcripts located downstream of DmTTF binding
sites was higher than in the control (see Fig. 2), a result in agreement
with the role of DmTTF as transcription termination factor. This
ﬁnding strongly indicates that DmTTF depletion relieved the block to
transcription and conﬁrms that in vivo the protein bound to both sites
arrests the progression of mtRNAP moving on both strands. Surpris-
ingly, DmTTF depletion decreased the level of transcripts of genes
mapping between the AT-rich region and the protein binding sites
(see Fig. 2). An interesting interpretation of this result is that DmTTF,
similarly to mTERF, may also act as transcription activation factor, so
that its depletion decreases transcription of those genes located
downstream of the transcription promoters that are presumably
placed in the AT-rich region. Alternatively, the decrease of transcrip-
tion could be due to a reduced availability of mtRNAP molecules that
are engaged in aberrant transcription extending beyond the termina-
tion sites.
We found that in D.Mel-2 RNAi cells DmTTF depletion did not alter
mtDNA copy number; however, a direct involvement of the protein in
mtDNA replication cannot be completely ruled out since the duration
and penetrance of RNAi in our system could not be sufﬁcient to revealdifferences in mtDNA level, given the lower turnover rate of mtDNA as
compared to mitochondrial RNAs.
Cotney et al. found that TFB2M over-expression in HeLa cells was
accompanied by an increase in the level of TFB1M [28]. This
observation suggests that perturbing the level of a factor could in
principle induce an alteration in the level of other factors participating
at the same process. Therefore, to conﬁrm that all the described
consequences of DmTTF depletion on mtDNA transcription were
primary effects, we measured the level of transcription initiation
factors TFAM and TFB2M in DmTTF RNAi cells by Real Time RT-PCR.
The obtained results (data not shown) indicate that DmTTF knock-
down does not alter the content of the initiation factors mRNAs.
The variation of mitochondrial transcript level caused by DmTTF
depletion prompted us to investigate whether this alteration could be
paralleled by a variation in the rate of synthesis of the corresponding
polypeptides. To address this issue, we ﬁrstly measured by Real Time
RT-PCR in DmTTF RNAi cells the level of the factor TFB1M that is
known to inﬂuence mitochondrial protein synthesis in Drosophila due
to its RNA methyltransferase activity [29]. We found no alteration of
the TFB1M mRNA level (data not shown). Next, we used [S35]-
methionine pulse-labelling of mitochondrial polypeptides in D.Mel-2
DmTTF-depleted cells, whose results are shown in Fig. 3A. It appears
that all the 13 mitochondrial translation products were detected by
SDS gel electrophoresis in knock-down as well as in control cells,
indicating that DmTTF depletion caused no qualitative alteration in
the proﬁle of mitochondrial polypeptides. However, the de novo
mitochondrial protein synthesis was substantially affected on a
Fig. 2. Genetic map of Drosophila melanogastermtDNA describing the effect of DmTTF depletion on mitochondrial transcription. The genes and the large non-coding A+T region are
shown. The two ellipses indicate the bound DmTTF. In blue are shown the regions ofmtDNAwhose corresponding transcripts decrease in their level following DmTTF knock-down; in
red are shown those regions whose transcript levels increase following DmTTF knock-down. The putative transcription promoters, indicated as P1, P2, P3 and P4, are shown on the
molecule, with the arrows indicating transcription direction.
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a factor of about 2, and the labelling of four polypeptides increasing by
a factor ranging approx. from 1.3 to 3 (Fig. 3B). The polypeptides
whose synthesis is mostly increased were ATP6 and ND4L, showing aFig. 3. Effect of DmTTF depletion on mitochondrial protein synthesis. (A) Mitochondrial trans
L-[35S]-methionine for 90 min in the presence of emetine and cycloheximide as reporte
polyacrylamide gel. Following phosphorimaging detection, the gel was stained with Co
quantiﬁcation of de novo polypeptide synthesis in RNAi cells relative to control cells, ﬁxed
deviations are indicated on the top of the bars. Statistically signiﬁcant differences (paired t3.1- and 3.3-fold variation, respectively. Only for three polypeptides
the labelling remained almost unchanged.
By comparing the level of de novo translation products with that
of the respective mRNA levels in knock-down cells [see ref. 27], welation products were labelled by incubating control and DmTTF RNAi D.Mel-2 cells with
d in [6]. Total cell proteins were fractionated on 15–20% exponential gradient SDS-
omassie Brilliant Blue for normalization (not shown). (B) Histogram showing the
as 1-value. Data represent the average of three independent experiments; standard
wo-tailed Student's t-test, Pb0.05) are marked with an asterisk.
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associated with a decrease in the level of the corresponding mRNAs.
Instead, no apparent correlation was found for those polypeptides
whose transcript level remained unchanged or were enhanced. It is
likely that alteration of mitochondrial transcription induced by
DmTTF depletion causes an imbalance of the relative mRNA trans-
lation. Imbalanced efﬁciency of mitochondrial protein synthesis was
also observed by Cotney et al. in HeLa cells over-expressing TFB2M
factor [28].
As a further approach in the in vivo study of DmTTF role, we
monitored the effects of DmTTF over-expression on mitochondrial
gene expression. The protein was over-expressed 10-fold in D.Mel-2
cells (Fig. 4A). The effect of such alteration on the level of
mitochondrial transcripts was analysed by measuring the content of
ND5 and cyt b mRNAs, two transcripts mapping downstream of
DmTTF binding site on either strand (see Fig. 2). As expected, DmTTF
over-expression diminished the level of both mRNAs, in agreement
with the role of the protein as transcription terminator (Fig. 4B).
Furthermore, pulse-labelling of mitochondrial polypeptides showed
that the de novo synthesis was decreased for almost all polypeptides,
including ND5 and cyt b (Fig. 4C, D). The described effects appear to
be driven by DmTTF over-expression since no variation in the level of
TFAM, TFB2M and TFB1M mRNAs was found (data not shown).Fig. 4. Effects of DmTTF over-expression. (A) Immunoblot analysis of D.Mel-2 mitochondria
mediated transfection. Ten μg of plasmid pMt/Hy (control) or pMt/DmTTF/Hy (over-expr
serum- and antibiotic-free medium according to the manufacturer's instructions. Cells were
24 h at 27 °C. Two hundred μg of mitochondrial proteins were fractionated on a 12% SDS-poly
against DmTTF or against Mn-SOD (StressGen) for normalization. (B) Effect of DmTTF ove
extracted from control and DmTTF over-expressing cells. Relative quantiﬁcation of mitochon
Bars indicate the relative content of transcripts in over-expressing with respect to contro
statistically signiﬁcant differences (Pb0.05) are marked with an asterisk. (C) Effect of DmTT
(D) Histogram showing the quantiﬁcation of de novo polypeptide synthesis in DmTTF over-
three independent experiments; standard deviations are indicated on the top of the bars. SIn a previous work [27] we proposed two models for Drosophila
mtDNA transcription. One model assumed that transcription depends
on one promoter only for each strand (P1 and P3, Fig. 2) located in the
AT-rich region, with the two DmTTF–DNA complexes functioning
mainly as attenuators. According to the other model, instead,
transcription of each strand should require at least two promoters,
each located at the 5′ end of each gene cluster (P1+P2 and P3+P4,
Fig. 2); in this case DmTTF bound to tRNASer(UCN)/ND1 site would
function as terminator in bothdirections,while at the tRNAGlu/tRNAPhe
site the factor would act as terminator in one direction and as
attenuator in the other. The here reported ﬁnding that the levels of cyt
b andND5mRNAs, and presumably of ND6 andND4mRNAs, decreased
following DmTTF over-expression suggests that they are transcribed
from promoters P1 and P3, according to the ﬁrst transcription model.
2.4. Structural and evolutionary analysis of the transcription
termination factors
Interesting considerations regarding transcription termination
factors derive from the analysis of the phylogenetic tree of MTERF
family proposed by Linder et al. [5]. Although sea urchin mtDBP and
Drosophila DmTTF were not included in any MTERF sub-family, they
seem to be evolutionary more close to MTERF1 and MTERF2 thanl lysate. About 107 cells were cultured in antibiotic-free medium for 16 h prior to lipid-
ession) were transfected in the presence of 50 μl of Cellfectin (Gibco-Invitrogen) and
incubated for 24 h at 27 °C. After incubation, cells were induced with 500 μM CuSO4 for
acrilamide gel, transferred to PVDF membrane and incubated with polyclonal antibodies
r-expression on the level of mitochondrial transcripts. After induction total RNA was
drial ND5 and cyt b transcripts was performed by Real Time RT-PCR as described [27].
l cells, ﬁxed as 1-value. Standard deviations are indicated on the top of the bars and
F over-expression on mitochondrial protein synthesis, carried out as reported in Fig. 3A.
expressing cells relative to control cells, ﬁxed as 1-value. Data represent the average of
tatistically signiﬁcant differences (Pb0.05) are marked with an asterisk.
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DmTTF are less clustered than the members of MTERF3 sub-family;
actually, multialignment of the amino acid sequence of the three
termination factors shows 5% amino acid identity and 28% amino acid
similarity that are quite low if compared with that of members of
MTERF3 sub-family (see below). A database searching for DmTTF
orthologues in other insects revealed intriguing features. In particular,
the termination factor in the beetle Tribolium castaneum displays
three deletions of about 20 residues, almost evenly distributed along
the entire molecule. On the contrary, the factor from several mosquito
species is about 200-amino acid longer than DmTTF, due to large
insertions in the N-terminal portion of the protein.
These observations support the notion that the primary structure
of the transcription termination factors is quite variable. Nevertheless,
all these proteins display the conserved mTERF motifs that are typical
of the MTERF family members. Fig. 5A, B shows the salient features of
the motifs in humanmTERF, sea urchin mtDBP and Drosophila DmTTF.
All the three proteins contain a variable number of the mTERF motifs
with some of them placed in corresponding position. The sequence
alignment of the motifs shows, as already reported in this review, the
conservation of a proline in position 8 and the presence of three LZ-
like heptads (Fig. 5C). An extensive characterization of human mTERF
performed by Attardi's group several years ago [8] pointed out the
existence of LZ heptads and two N- and C-terminal basic domains; the
leucine-zipper motifs were suggested to establish intramolecular
interactions aimed at bringing the basic domains in close contact with
DNA. A similar arrangement was also suggested for mtDBP; DmTTF,
instead, lacks evident terminal basic domains despite the presence ofFig. 5. Alignment of themTERFmotifs in the transcription termination factorsmTERF, mtDBP
P. lividusmtDBP and Drosophila DmTTF, according to SMART tool (http://smart.embl-heidel
(B) Multiple alignments of the mTERF motifs obtained with ClustalW2 (PBIL). Initials of spe
motif, are reported to the left. Similar amino acids are in bold, conserved blocks are shaded
motifs shown in (B). The amino acid positions in the putative leucine zippers (a–g) are alsothe LZ motifs. It cannot be excluded that the LZ heptads of the
termination factors, besides stabilizing the tertiary structure of the
protein, could also be used to establish interactions with other factors.
2.5. The transcription termination factors: multiple function proteins
The emerging picture from the above reported observations
highlights a structural variability of the transcription termination
factors, which underlines their functional ﬂexibility. Termination
factors exert different roles in the transcription process. In particular,
mTERF controls termination of transcription of the H-strand rDNAunit
[7,8] and contributes to determine the higher level of rRNAs with
respect to mRNAs; moreover the protein could also be responsible for
L-strand transcription termination at the same canonical binding site
[11]. Contrary to human mTERF, the invertebrate proteins mtDBP and
DmTTF do not bind at the 3′ end of the ribosomal genes and do not
seem to directly regulate rRNA level nor the 3′ end formation of the
transcripts [19–21,25–27]. In invertebrates it is likely that termination
factors act mainly in coordinating the passage of the transcription
machineries moving on opposite strands; this would serve to avoid
forced transcription pausing due to head-on collisions of the
machineries, thus safeguarding the integrity of the genome [30–32].
It cannot be excluded, however, that such a role might also be played
by the human factor mTERF.
In addition, the termination factors seem to perform a role in
initiation of transcription. In particular, as already mentioned, mTERF
seems to control transcription initiation by means of the looping
mechanism [12]. Transcript quantiﬁcation in knock-down cellsand DmTTF. (A) Diagram showing themodular architecture of humanmTERF, sea urchin
berg.de/). The position of the mTERF motifs on the sequences is indicated with ellipses.
cies name, together with the number indicating the progressive position of the mTERF
in yellow. (C) Graphical representation, as HMM sequence logo, of the aligned mTERF
indicated.
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initiation. This could be achieved through a DNA looping mechanism
involving the simultaneous interaction of DmTTF with one canonical
binding site and a still unknown site placed in proximity of the
promoters in the AT-region. The existence of two already deﬁned
binding sites prompted us to investigate the possibility that they could
be involved in DNA looping by DmTTF, although this loop would not
be directly linked to transcription initiation. In vitro experiments (not
shown) clearly demonstrate that DmTTF is not able to simultaneously
bind the two sites.
The multiplicity of functions of transcription termination factors is
further underlined by the ﬁnding that the human and sea urchin
proteins play roles in mitochondrial replication, namely, mtDBP in the
negative control of the D-loop expansion [22] and mTERF in the
regulation of replication pausing [13].
3. The mitochondrial transcription repressors
MTERF3 is the other sub-family of theMTERF family whose protein
members have been quite extensively characterized. In a recent report
Park et al. [33] provided information on the mammalian MTERF3. The
mature protein, about 350 amino acids, was shown to localize to
mitochondria. MTERF3 is an essential protein because homozygous
MTERF3 knock-out mouse embryos died in the midgestation. Tissue-
speciﬁc gene inactivation produced vital mice, though with a
shortened life span, and differently affected skeletal muscle and
heart causing only in the latter evident mitochondrial dysfunction. In
particular, an aberrant mtDNA transcription mainly consisting in an
increased initiation at both promoters HSP and LSP was observed.
Moreover, it was demonstrated by ChIP experiments that MTERF3
binds the mtDNA promoter region. All together, these data suggested
for MTERF3 a role as mitochondrial transcriptional repressor. In the
absence of information on a sequence speciﬁc binding of the protein to
mtDNA, it can be hypothesized that MTERF3 function is mediated by
interactions with the identiﬁed transcription initiation factors as well
as with still unknown proteins.Fig. 6. Effect of over-expression and knock-down of D-MTERF3. (A) Immunoblot analysis of m
(over-expression). Cells were cultured and processed as described in the legend to Fig. 4
expression on the level of mitochondrial transcripts. Total RNA was extracted from cont
transcripts were carried out as reported in the legend to Fig. 4B. (C) Relative abundance of
respect to control cells, ﬁxed as 1-value. Standard deviations are indicated on the top of theOur work in Drosophila has provided further interesting informa-
tion on MTERF3. We characterized the Drosophila homologue D-
MTERF3, a protein of 323 residues, which localizes tomitochondria [6].
Preliminary experiments aimed at determining its sub-mitochondrial
localization showed that the behaviour of D-MTERF3 is typical of a
peripheral membrane protein. On the other hand we cannot rule out
that the protein, besides being linked to the innermembrane, is able to
interact with the DNA as reported for the mammalian homologue
MTERF3 [33].
To obtain insights into the function of D-MTERF3, we analysed the
effect of its over-expression and depletion onmitochondrial functions.
Fig. 6A shows that over-expression of the protein resulted in an
increased level of 40-fold. We analysed in D-MTERF3 over-expressing
cells the level of three mitochondrial transcripts, srRNA, COI and ND2,
which map on both strands immediately downstream of the AT-rich
control region. As revealed by Real Time RT PCR analysis, the level of
the transcripts was decreased in the range of 0.2–0.6 fold (Fig. 6B); no
noticeable effect was detected on the level of mitochondrial factors
TFAM, TFB1M, TFB2M (Fig. 6C), nor on mtDNA copy number (data not
shown), thus suggesting that the observed alterations of the
mitochondrial transcripts are directly linked to D-MTERF3 over-
expression. These results tend to propose for the Drosophila factor a
role as negative regulator of mitochondrial transcription in agreement
with that of mammalian MTERF3.
In regard to the effect of D-MTERF3 depletion on themitochondrial
functions, we reported in a previous work that it did not inﬂuence the
level of several sense and antisense mitochondrial transcripts. D-
MTERF3 knock-down, however, produced an overall decrease in de
novo synthesis of mitochondrial polypeptides, with ND1 being the
most affected [6]. Herewemeasured the level of themRNAs for factors
TFAM, TFB2M and TFB1M also in D-MTERF3 depleted cells. Fig 6C
shows that protein depletion was associated to a decrease in the level
of TFAM and TFB1M, whereas that of TFB2M remained unchanged;
TFAM decrease was also conﬁrmed by immunoblotting (data not
shown). Therefore, a tentative explanation of the general decline in
mitochondrial protein synthesis observed in D-MTERF3 knock-downitochondrial lysate fromD.Mel-2 cells carrying pMt/Hy (control) or pMt/D-MTERF3/Hy
A. Antibodies were against D-MTERF3 or against Mn-SOD. (B) Effect of DmTTF over-
rol and D-MTERF3 over-expressing cells and relative quantiﬁcation of mitochondrial
mRNAs for TFB1M, TFB2M and TFAM in D-MTERF3 over-expressing or RNAi cells with
bars; statistically signiﬁcant differences (Pb0.05) are marked with an asterisk.
310 M. Roberti et al. / Biochimica et Biophysica Acta 1787 (2009) 303–311cells could be the decrease in the level of TFB1M, a factor that is
implicated in translation efﬁciency [29]. The unchanged level of the
mitochondrial transcripts might be ascribed to the down-regulation of
TFAM in D-MTERF3 depleted cells. Since TFAM is an activator of
transcription [3,4], its diminished level could have counterbalanced
the enhanced transcription caused by the removal of repressor D-
MTERF3.
MTERF3 proteins are widespread in Metazoa as they can be clearly
detected in worms, insects, echinoderms and vertebrates. They
display a higher conservation of primary structure with respect to
that of the transcription termination factors. In fact, multialignment of
human, sea urchin and Drosophila MTERF3 shows 20% amino acid
identity and 32% similarity. Moreover, the conservation of ﬁve mTERF
motifs in corresponding position is evident going from C.elegans to
human [6]. These observations suggest that MTERF3 is subjected to
stronger functional constraints than the termination factors. Though
the function of MTERF3 has been studied in mammalian and Droso-
phila only, it is possible to speculate that the sequence conservation of
this factor implies a similar function in all Metazoa. It would result
that, in spite of the wide variation in the gene arrangement, all the
mitochondrial genomes seem to require the transcription repressor.
Since MTERF3 function could need protein–protein interactions, it is
possible that the mTERF motifs of the repressor serve to contact other
proteins that could mediate binding of MTERF3 to the promoter
regions.
4. Conclusions and perspectives
The here reported evidence highlights a relevant role of the MTERF
family proteins in mitochondrial gene expression. Members of this
family include the transcription termination factors that may perform
multiple roles. The information about MTERF3 outlines a role of
negative regulator of mitochondrial transcription; this knowledge
adds a new component to the transcription machinery and suggests
also the involvement of yet unknown regulatory factors as possible
interacting partners of MTERF3. Therefore, the emerging scenario is
that mtDNA expression could be ﬁnely tuned in response to cellular
demands by the coordinated action of the activating factors TFAM and
TFB1/2M [3], the repressor MTERF3 and the termination factor.
Still obscure is the role ofMTERF2 andMTERF4. Preliminary reports
from the laboratory of Gustafsson suggest that human MTERF4 binds
to the D-loop region and interacts with a mitochondrial protein
containing a RNAmethyltransferase domain [34]. MTERF2 (mitochon-
drial transcription termination factor-like or mTERF.D3) was partially
characterized by the groups of Chen and Moraes [35,36]. The human
protein displays 29% amino acid identity and 52% similarity with
mTERF. The two factors show an opposite expression behaviour to
serum: MTERF2 is inhibited by addition of serum to serum-starved
cultured cells, whereas mTERF is rather induced. Moreover, immuno-
histochemistry experiments and sub-cellular fractionation analysis
showed that MTERF2 is a mitochondrial matrix protein and is
associated with the inner membrane. The complete elucidation of
the role of theMTERF familymemberswill contribute to the unraveling
of the molecular mechanisms of mtDNA transcription and replication.
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